Table 1.
Distribution of co-cited journals in prostate cancer research.
| Journal | Frequency | Degree | Centrality |
|---|---|---|---|
| EUR UROL | 2286 | 43 | 0.1 |
| NEW ENGL J MED | 2259 | 41 | 0.06 |
| J UROLOGY | 2104 | 40 | 0.06 |
| J CLIN ONCOL | 1812 | 40 | 0.08 |
| CA-CANCER J CLIN | 1780 | 42 | 0.11 |
| JAMA-J AM MED ASSOC | 1684 | 33 | 0.02 |
| PLOS ONE | 1624 | 46 | 0.1 |
| CANCER RES | 1517 | 72 | 0.15 |
| CANCER-AM CANCER SOC | 1451 | 37 | 0.02 |
| BJU INT | 1389 | 30 | 0.02 |
| INT J CANCER | 1330 | 34 | 0.05 |
| PROSTATE | 1293 | 35 | 0.04 |
| UROLOGY | 1283 | 25 | 0.02 |
| JNCI-J NATL CANCER I | 1250 | 31 | 0.04 |
| CLIN CANCER RES | 1225 | 56 | 0.07 |
| LANCET | 1220 | 25 | 0.01 |
| BRIT J CANCER | 1124 | 36 | 0.04 |
| P NATL ACAD SCI USA | 1090 | 60 | 0.06 |
| NATURE | 1083 | 63 | 0.08 |
| CANCER EPIDEM BIOMAR | 1065 | 34 | 0.08 |